The Long-Term Cost-Effectiveness of Twice-Daily Exenatide with Insulin Glargine Versus Once-Daily Liraglutide with Insuline Detemir in Adult Patients with Type 2 Diabetes in Russia
Abstract
Authors
I Krysanov M Tiapkina
I Krysanov M Tiapkina
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now